X

Blog

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD and ODD Designations

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes.…

QualityStocks

QualityStocksNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Tapping Emerging Technologies to Address Unmet Mobile Money Needs

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is working to develop a global financial technology ecosystem. “The company is keen on…

QualityStocks

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic Berubicin May Provide Much-Needed Benefit for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a focus on brain…

QualityStocks

QualityStocksNewsBreaks – Safety Shot (NASDAQ: SHOT) Rebrands with New Name, Ticker to Focus on New Business

Safety Shot (NASDAQ: SHOT), formerly known as Jupiter Wellness, has announced that effective today it has changed its name to…

QualityStocks

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological…

QualityStocks

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Leveraging Technology, Innovative Services to Enhance US Safety

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is leveraging technology to…

QualityStocks

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announce New Mining Updates; Confirm Timeline for NI-43101 Compliant MRE Report Publication

Eloro Resources recently provided an update on the company’s ongoing exploratory drill work Recent findings revealed a number of holes…

QualityStocks

Lexaria Bioscience Corp. (NASDAQ: LEXX) is On Track for IND Application with the FDA for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria’s IND application for its U.S. Phase 1b Hypertension Clinical Study, HYPER-H23-1, remains on track despite setbacks Work mostly under…

QualityStocks

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) CEO Spotlighted in Recent ‘Bloomberg Technology’ Segment

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, was featured in the “Bloomberg Technology” daily…

QualityStocks

QualityStocksNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) in Unique ‘Only Ones in Town’ Position

First Tellurium (CSE: FTEL) (OTC: FSTTF) president and CEO Tyron Docherty was recently featured as a guest on the Bell2Bell…

QualityStocks